中基健康(000972.SZ):擬將威晟天海公司租賃期間投資購置的固定資產轉讓與紅色番茄
格隆匯5月23日丨中基健康(000972.SZ)公佈,下屬全資子公司新疆中基紅色番茄產業有限公司與新疆威晟天海番茄製品有限責任公司(簡稱“威晟天海公司”)於2019年至2020年簽訂《番茄加工廠租賃合同》,紅色番茄將下屬新疆中基紅色番茄產業有限公司天海分公司租賃給威晟天海公司,租賃合同於2021年6月25日終止,相關租賃費用已結清。租賃期間,威晟天海公司為正常開展生產經營活動,對天海分公司投資購置部分固定資產。鑑於該租賃事項已終止,經友好協商,紅色番茄擬與威晟天海公司簽訂《資產轉讓協議》,將威晟天海公司租賃期間投資購置的固定資產轉讓與紅色番茄。成交金額為747.46萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.